Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy

Bibliography

• Kaminow L, Schimschock JR, Hammer AE, Vuong A. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy. Epilepsy Behav 2003;4:659-66
   PubMed Web of Science ®Google Scholar
• Potschka H, Fedrowitz M, Lo¨scher W. P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood–brain barrier: evidence from microdialysis experiments in rats. Neurosci Lett 2002;327:173-6
   PubMed Web of Science ®Google Scholar
• Colombo G, Lorenzini L, Zironi E, et al. Brain distribution of ribavirin after intranasal administration. Antiviral Res 2011;92:408-14
   PubMed Web of Science ®Google Scholar
• Fazil M, Md S, Haque S, et al. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci 2012;47:6-15
   PubMed Web of Science ®Google Scholar
• Seju U, Kumar A, Sawant KK. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Acta Biomater 2011;7:4169-76
   PubMed Web of Science ®Google Scholar
• Eskandari S, Varshosaz J, Minaiyan M, Tabbakhian M. Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model. Int J Pharm 2011;242:363-71
   Google Scholar
• Haque S, Md S, Fazil M, et al. Venlafaxine loaded chitosan NPS for brain targeting: pharmacokinetic and Pharmacodynamic evaluation. Carbohydr Polym 2012;89:72-9
   PubMed Web of Science ®Google Scholar
• Cho HJ, Kua WS, Termsarasaba U, et al. Development of udenafil-loaded microemulsions for intranasal delivery: in vitro and in vivo evaluations. Int J Pharm 2012;423:153-60
   PubMed Web of Science ®Google Scholar
• Piaoa HM, Balakrishnana P, Choa HJ, et al. Preparation and evaluation of fexofenadine microemulsions for intranasal delivery. Int J Pharm 2010;395:309-16
   PubMed Web of Science ®Google Scholar
• Alam MI, Baboota S, Ali J, et al. Intranasal administration of nanostructured lipid carriers containing CNS acting drug : pharmacodynamic studies and estimation in blood and brain. J Psychiatr Res 2012;46:1133-8
   PubMed Web of Science ®Google Scholar
• Muller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002;242:121-8
   PubMed Web of Science ®Google Scholar
• Hu FQ, Jiang SP, Du YZ, et al. Preparation and characterization of stearic acid nanostructured lipid carrier by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces 2005;45:197-203
   Google Scholar
• Kovacevic A, Savic S, Vuleta G, et al. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Int J Pharm 2011;406:163-72
   PubMed Web of Science ®Google Scholar
• Liu CH, Wu CT. Optimization of nanostructured lipid carriers for lutein delivery. Colloids Surf A Physicochem Eng Aspects 2010;353:149-56
   Web of Science ®Google Scholar
• Subedi RK, Kang KW, Choi HK. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sci 2009;37:508-13
   PubMed Web of Science ®Google Scholar
• Thakur A, Joshi N, Shanmugam T, Banerjee R. Proapoptotic miltefosine nanovesicles show synergism with paclitaxel: implications for glioblastoma multiforme therapy. Cancer Lett 2013;334(2):274-83
   PubMed Web of Science ®Google Scholar
• Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123-33
   PubMed Web of Science ®Google Scholar
• Castel-Branco MM, Almeida AM, Falcao AC, et al. Lamotrigine analysis in blood and brain by high-performance liquid chromatography. J chromatogr B Biomed Sci Appl 2001;755:119-27
   PubMedGoogle Scholar
• Matar KM, Nicholls PJ, Bawazir SA, et al. A rapid liquid chromatographic method for the determination of LMT in plasma. J Pharm Biomed Anal 1998;17:525-31
   PubMed Web of Science ®Google Scholar
• Sudha K, Rao AV, Rao A. Oxidative stress and antioxidants in epilepsy. Clin Chim Acta 2001;303:19-24
   PubMed Web of Science ®Google Scholar
• Sedlak J, Lindsay RH. Estimation of total, protein bound and nonprotein sulfhydryl group in tissue with Ellman’s reagent. Anal Biochem 1968;25:192-205
   PubMed Web of Science ®Google Scholar
• Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophy 1959;82:70-7
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:359-64
   PubMed Web of Science ®Google Scholar
• Shah KA, Date AA, Joshi MD, Patravale VB. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm 2007;345:163-71
   PubMed Web of Science ®Google Scholar
• Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985;60:110-11
   PubMedGoogle Scholar
• Kumar M, Misra A, Babbar AK, et al. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int J Pharm 2008;358:285-91
   PubMed Web of Science ®Google Scholar
• Md S, Khan RA, Mustafa G, et al. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, Pharmacokinetic and Scintigraphy study in mice model. Eur J Pharm Sci 2013;48:393-405
   PubMed Web of Science ®Google Scholar
• Pahuja M, Mehla J, Gupta YK. Anticonvulsant and antioxidative activity of hudroalcoholic extract of tuber of Orchis Muscula in pentylenetetrazole and maximal electroshock induced seizure in rats. J Ethnopharmacol 2012;142:23-7
   PubMed Web of Science ®Google Scholar
• Tiwari R, Pathak K. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int J Pharm 2011;415:232-43
   PubMed Web of Science ®Google Scholar
• Singh A, Ahmad I, Akhter S, et al. Nanocarrier Based Formulation of Thymoquinon Improves Oral Delivery: stability Assessment, In-Vitro and In-Vivo Studies. Colloids Surf B Biointerfaces 2013;102:822-32
   PubMed Web of Science ®Google Scholar
• Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev 2011;63(6):456-69
   PubMed Web of Science ®Google Scholar
• Jia L, Zhang D, Li Z, et al. Nanostructured lipid carriers for parenteral delivery of silybin: biodistribution and pharmacokinetic studies. Colloids Surf B Biointerfaces 2010;80:213-18
   PubMed Web of Science ®Google Scholar
• Na L, Mao S, Wang J, Sun W. Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats. Int J Pharm 2010;397:59-66
   PubMed Web of Science ®Google Scholar
• Sullivan PG. Interventions with neuroprotective agents: novel targets and opportunities. Epilepsy Behav 2005;7:12-17
   Google Scholar
• Trojnar MK, Malek R, Chroscinska M, et al. Neuroprotective effects of antiepileptic drugs. Pol J Pharmacol 2002;54:557-66
   PubMedGoogle Scholar